Events and Presentations
Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting 2025
Members of Immunic’s management, medical and preclinical teams will be available throughout the event at booth #911. Additionally, preclinical data highlighting lead asset, nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), will be presented in a poster presentation.
- Poster Title: In Preclinical Models, Vidofludimus Calcium Exhibits Potential Neuroprotective Effects in Multiple Sclerosis by Modulating Nurr1
- Presenting Author: Amelie Schreieck, Ph.D., Senior Manager Biomarker Development, Immunic
- Abstract ID: 10271
- Poster Board Label: NDM01
- Date: Thursday, May 29, 2025
- Time: 5:00 – 7:00 pm MST
